SciELO - Scientific Electronic Library Online

 
vol.30 issue3How to choose the best NOAC for patients with atrial fibrillationAtrial fibrillation and its association with cognitive decline, cognitive impairment, and dementia in the absence of clinical stroke: a review of the evidence and possible mechanisms author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Related links

Share


Revista Uruguaya de Cardiología

Print version ISSN 0797-0048On-line version ISSN 1688-0420

Abstract

MCLEOD, Christopher J  and  GERSH, Bernard J. Anticoagulation in the elderly patient with atrial fibrillation. Rev.Urug.Cardiol. [online]. 2015, vol.30, n.3, pp.385-396. ISSN 0797-0048.

Increasing age stands out as one of the most powerful risk factors for stroke in patients with atrial fibrillation. With the steadily increasing age of the global population, questions regarding the optimal anticoagulation strategy in the elderly are pervasive and often present highly complex clinical dilemmas. This group of patients is at increased risk of bleeding related to multiple other comorbidities, higher rates of falling, and polypharmacy -especially the anti-platelet agents. The elderly patient is more sensitive to warfarin, and coupled with higher rates of intracranial bleeding, the newer anticoagulants present an attractive alternative in selected subgroups. This review is aimed at contextualizing the problem, and providing a practical, balanced approach to managing the inescapable predicament of bleeding versus thromboembolic stroke in this high-risk group.

Keywords : ATRIAL FIBRILLATION; ANTICOAGULANTS; AGED.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License